跳至主要内容
临床试验/ITMCTR2000003798
ITMCTR2000003798招募中1 期

The clinical research of effect of YiGuanJian Decoction on liver cirrhosis post HBV (Liver-Kidney Yin deficiency syndrome)

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) Ages 18 to 65, regardless of gender;
  • (2) It conforms to the western medicine diagnostic criteria of liver cirrhosis post HBV, and the TCM syndrome differentiation criteria of liver-kidney Yin deficiency syndrome, and the CTP score is 7-9 points (Grade B);
  • (3) Patients who are taking or preparing to take Entecavir;
  • (4) The person or his guardian agrees to participate in the randomized controlled trial and signs the informed consent.

排除标准

  • (1) Liver failure;
  • (2) Hepatitis with other hepatitis virus infection, fatty liver, long-term alcohol consumption or other chronic severe hepatitis;
  • (3) Women who are pregnant or preparing for pregnancy, or women who are breastfeeding;
  • (4) Severe underlying diseases: severe COPD, severe renal insufficiency, chronic congestive heart failure, etc.
  • (5) Patients with immunodeficiency, such as malignant tumor, organ transplantation and taking immunosuppressive drugs or glucocorticoids within the last 3 months;
  • (6) Patients participating in other clinical trials;
  • (7) Other conditions that the researcher believes are not suitable for inclusion.

研究者

发起方
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

相似试验